Table 2.
Outcomes about GOPC utilization, blood pressure, medication change and physical test in intervention and usual care groups at follow-up
| Outcomes | Intervention (N = 24) | Usual care (N = 25) | p-value |
|---|---|---|---|
| No. of attendance in GOPC | 0.8 (1.0) | 2.0 (0.8) | < 0.001* |
| Blood Pressure | |||
| 24 h Systolic ABPM (mmHg) | 126.2 (8.7) | 124.8 (10.4) | 0.60 |
| 24 h diastolic ABPM (mmHg) | 78.4 (11.3) | 79.8 (9.0) | 0.88 |
| Daytime Systolic ABPM (mmHg) | 128.2 (8.4) | 126.9 (9.3) | 0.41 |
| Daytime diastolic ABPM (mmHg) | 79.9 (10.9) | 81.6 (8.9) | 0.86 |
| Office systolic BP (mmHg) | 125.0 (10.0) | 129.8 (9.5) | 0.089 |
| Office diastolic BP (mmHg) | 73.0 (6.6) | 71.0 (8.4) | 0.38 |
| Change in medications | |||
| Decrease | 5 (21%) | 1 (4%) | 0.072 |
| No change | 19 (79%) | 24 (96%) | |
| Physical Test | |||
| BMI (kg/m2) | 24.7 (4.0) | 26.1 (5.5) | 0.32 |
| eGFR, mean mL/min/1.73m2 (SD) | 90.1 (13.4) | 82.6 (14.0) | 0.063 |
| Fasting Glucose (mmol/L) | 5.3 (0.4) | 5.5 (0.7) | 0.40 |
| HDL (mmol/L) | 1.5 (0.3) | 1.3 (0.3) | 0.054 |
| LDL (mmol/L) | 3.5 (0.7) | 3.0 (0.9) | 0.037* |
| Triglycerides (mmol/L) | 1.3 (0.5) | 1.3 (0.5) | 0.94 |
P-value < 0.05 (marked by *) was considered statistically significant